OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
December 15, 2019
This article describes the revision process and the resulting publication of proposed and official updates for pharmacopoeias around the world.
Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.
Find links to pertinent regulatory and standard setting resources, guidance documents, and guidelines.
Long a staple for quality by design and solid dosage form manufacturing, design of experiments is becoming an integral part of biopharma upstream process development.
Warning letters tell the tale of missteps by drug companies and offer a path to compliance for quality teams that monitor these enforcement actions.
Quality risk management plans provide identified actions to ensure a continuous supply of safe
and effective drug products
Too narrow a focus on regulatory compliance may prevent organizations from embracing-and profiting from-quality and operational excellence.
An effective surveillance program for monitoring the activities of pharmacopoeias around the world requires processes, people, and tools from across a company.